健世科技-B(09877)：LUX-VALVE PLUS在巴西成功完成首例救治临床植入手术
健世科技-B(09877)发布公告，近期，公司自主研发的经颈静脉三尖瓣置换产品LuX-Valve Plus在巴西Rede D’OR医院成功完成首例救治临床植入手术。本次救治临床手术过程顺利，术后即刻显示，患者植入的瓣膜稳定，无反流或瓣周漏，二尖瓣反流也随之减轻;术后患者临床表现、心脏功能及生活质量均出现显著改善。来自Rede D’OR医院的术者Vincius Esteves教授对Lux-Valve Plus及其本次救治临床手术高度认可，评价这是经导管三尖瓣介入治疗术式在拉丁美洲的首次应用。本次LuX-ValvePlus的成功应用将为拉丁美洲地区的三尖瓣反流患者带来救治的可能性。本次救治临床手术的成功，证明了Lux-Valve Plus产品适用范围广、可靠性高及操作简单。
公司正在持续推进LuX-Valve系列产品在中国国家药品监督管理局获批商业化、欧洲CE认证临床试验、美国食品及药物管理局注册临床试验，与此同时，持续推进其于全球范围内商业化和公司国际化战略的实现。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.